Showing results (101-110 of 718) with videos related to

Sort By:
Pageof 72
Pneumologie (Stuttgart, Germany)|June 14, 2023
Point-of-care procalcitonin testing for lower respiratory tract infection in pulmonary outpatient care has limited valueDavid Raupach, Oana Joean, Jan Fuge, et al.
Expert Review of Respiratory Medicine|May 17, 2016
Can we improve clinical outcomes in patients with pneumonia treated with antibiotics in the intensive care unit?David P Nicolau, George Dimopoulos, Tobias Welte, et al.
ERJ Open Research|November 26, 2024
Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trialLina Brinkmann, Jan Fuge, Tobias Welte, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 30, 2018
Infection transmission among lung transplant couplesJessica Rademacher, Jan Fuge, Tobias Welte, et al.
Clinical Pharmacokinetics|August 27, 2005
Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteersOlaf Burkhardt, Heino Stass, Uwe Thuss, et al.
Recent Patents on Anti-Infective Drug Discovery|January 29, 2008
Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumoniaOlaf Burkhardt, Mathias Wilhelm Pletz, Claus-Peter Mertgen, et al.
ERJ Open Research|May 5, 2023
Influence of anti-interleukin (IL)-5/anti-IL-5 receptor-α treatment on work productivity in patients with severe eosinophilic asthmaNora Drick, Lina Brinkmann, Jan Fuge, et al.
BMC Pulmonary Medicine|July 20, 2018
Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment responseNora Drick, Benjamin Seeliger, Tobias Welte, et al.
Pulmonary Pharmacology & Therapeutics|October 13, 2004
Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytesUwe R Juergens, Tanja Engelen, Kurt Racké, et al.
Frontiers in Pharmacology|October 1, 2025
Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysisAdrian Gillissen, Thorsten Reineke, Martin Burkart, et al.
Pageof 72